NCT05504278 2025-01-27Efficacy and Safety of IBI351 in Combination With Chemotherapy in Advanced Non-squamous Non-small Cell Lung Cancer Subjects With KRAS G12C MutationInnovent Biologics (Suzhou) Co. Ltd.Phase 1 Recruiting144 enrolled